RS57056B1 - Nepatogeni soj f18 e.coli i njegova primena - Google Patents

Nepatogeni soj f18 e.coli i njegova primena

Info

Publication number
RS57056B1
RS57056B1 RS20180360A RSP20180360A RS57056B1 RS 57056 B1 RS57056 B1 RS 57056B1 RS 20180360 A RS20180360 A RS 20180360A RS P20180360 A RSP20180360 A RS P20180360A RS 57056 B1 RS57056 B1 RS 57056B1
Authority
RS
Serbia
Prior art keywords
strain
coli
live
pathogenic
animals
Prior art date
Application number
RS20180360A
Other languages
English (en)
Serbian (sr)
Inventor
John Morris Fairbrother
Éric Nadeau
Clarisse Desautels
Original Assignee
Prevtec Microbia Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prevtec Microbia Inc filed Critical Prevtec Microbia Inc
Publication of RS57056B1 publication Critical patent/RS57056B1/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185—Escherichia
    • C12R2001/19—Escherichia coli
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
RS20180360A 2012-07-20 2013-07-18 Nepatogeni soj f18 e.coli i njegova primena RS57056B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261674179P 2012-07-20 2012-07-20
PCT/CA2013/000660 WO2014012172A1 (en) 2012-07-20 2013-07-18 Non-pathogenic f18 e. coli strain and use thereof
EP13819873.4A EP2875121B1 (en) 2012-07-20 2013-07-18 Non-pathogenic f18 e. coli strain and use thereof

Publications (1)

Publication Number Publication Date
RS57056B1 true RS57056B1 (sr) 2018-05-31

Family

ID=49948133

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20180360A RS57056B1 (sr) 2012-07-20 2013-07-18 Nepatogeni soj f18 e.coli i njegova primena

Country Status (17)

Country Link
US (3) US9453195B2 (https=)
EP (1) EP2875121B1 (https=)
JP (1) JP6278960B2 (https=)
KR (1) KR102171028B1 (https=)
CN (1) CN104736695B (https=)
BR (1) BR112015001175B1 (https=)
CA (1) CA2879155C (https=)
DK (1) DK2875121T3 (https=)
ES (1) ES2663019T3 (https=)
HU (1) HUE036545T2 (https=)
MX (1) MX363057B (https=)
PH (1) PH12015500091A1 (https=)
PL (1) PL2875121T3 (https=)
PT (1) PT2875121T (https=)
RS (1) RS57056B1 (https=)
RU (1) RU2670882C9 (https=)
WO (1) WO2014012172A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112015001175B1 (pt) 2012-07-20 2022-03-03 Elanco Canada Limited Composição compreendendo uma cepa de e.coli isolada e usos da mesma
KR102567744B1 (ko) * 2015-02-11 2023-08-18 에바 뉴트리션 인크 생존 가능한 대장균을 삽입하기 위한 향상된 건조 기질, 이의 제조 방법 및 용도
KR101715625B1 (ko) * 2015-06-02 2017-03-13 대한민국(농림축산식품부 농림축산검역본부장) 부종병 독소를 생산하는 대장균, 이를 이용한 부종병 독소의 생산방법 및 이를 포함하는 돼지 부종병 예방용 백신 조성물
CA3027896C (en) * 2016-06-14 2021-07-13 Prevtec Microbia Inc. Animal feed pellets including a feed additive, method of making and of using same
EP3648769A4 (en) * 2017-06-30 2021-04-07 The Rockefeller University HUMAN INTESTINAL FLORA-DERIVED N-ACYLAMIDES FOR THE TREATMENT OF HUMAN DISEASES
CN107523529B (zh) * 2017-10-20 2021-03-12 林州中农颖泰生物肽有限公司 一种利用大肠杆菌生产肠杆菌肽的工艺及其应用
CN109504643B (zh) * 2018-11-27 2022-06-10 扬州大学 整合四拷贝功能性f18菌毛操纵子基因的益生菌克隆株、构建方法及应用
CN109628361B (zh) * 2018-11-27 2022-08-19 扬州大学 整合双拷贝功能性f4菌毛操纵子基因猪源益生菌ep1克隆株、构建方法及应用
CN114752531B (zh) * 2022-04-29 2023-05-26 扬州大学 一株同时表达f4和f18菌毛的猪源大肠杆菌无毒分离株及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2125455C1 (ru) * 1996-09-25 1999-01-27 Саратовская научно-исследовательская ветеринарная станция Способ профилактики диареи молодняка сельскохозяйственных животных
US6355859B1 (en) 1997-05-20 2002-03-12 Biotechnology Research And Development Corporation Interactions between genotype and diet in swine that prevent E. coli associated intestinal disease
US5965128A (en) * 1997-08-13 1999-10-12 University Of Georgia Research Foundation Inc. Control of enterohemorrhagic E. coli 0157:H7 in cattle by probiotic bacteria and specific strains of E. coli
WO2000006764A1 (en) * 1998-07-30 2000-02-10 Wisconsin Alumni Research Foundation Gastrointestinal bacterial antibody factories
US6304216B1 (en) 1999-03-30 2001-10-16 Conexant Systems, Inc. Signal detector employing correlation analysis of non-uniform and disjoint sample segments
HU221664B1 (hu) * 1999-03-31 2002-12-28 MTA Állatorvostudományi Kutatóintézete Élő, szájon át adható Escherichia coli vakcina készítésére alkalmas törzs a sertések választási hasmenésének megelőzésére és a törzs előállítására alkalmas eljárás
IL130303A0 (en) * 1999-06-03 2000-06-01 M G Novobiotech Ltd A bacterial strain processed plant extracts and probiotic compositions for human and veterinary use
BR0116178A (pt) 2000-11-30 2003-10-14 Bio Balance Corp Cepa bacterial, composição probiótica compreendendo uma cepa bacterial, formulação compreendendo pelo menos uma fração volátil de um extrato de planta, aditivo alimentar, processo de preparação de uma fração volátil de uma planta, processo de preparação de uma formulação terapêutica, processo de crescimento de uma cepa bacterial, processo de manufatura de uma composição probiótica, processo de preparo de uma composição probiótica, processo de preparo de uma composição incluindo microorganismos viáveis, dispensador de microorganismo, método de bio controle de um organismo, método para eliminar uma poluição de óleo, método de recuperação de fumaças org‰nicas, produto alimentar e método de preparo inicial para um processo de fermantação
KR101148255B1 (ko) 2002-10-04 2012-08-08 다니스코 유에스 인크. 고수율을 갖는 1,3-프로판디올의 생물학적 제조 방법
HUE024565T2 (hu) * 2004-02-03 2016-02-29 Prevtec Microbia Inc Élõ baktériumok alkalmazása növekedésserkentésre állatokban
CA2566617C (en) * 2004-05-14 2013-12-31 Agtech Products, Inc. Method and composition for reducing e.coli disease and enhancing performance using bacillus
US7927586B2 (en) * 2008-07-08 2011-04-19 South Dakota State University Vaccine for porcine post-weaning diarrhea caused by enterotoxigenic Escherichia coli
BR112015001175B1 (pt) 2012-07-20 2022-03-03 Elanco Canada Limited Composição compreendendo uma cepa de e.coli isolada e usos da mesma

Also Published As

Publication number Publication date
CA2879155A1 (en) 2014-01-23
US10258654B2 (en) 2019-04-16
ES2663019T3 (es) 2018-04-10
JP2015525566A (ja) 2015-09-07
US20150152377A1 (en) 2015-06-04
RU2670882C9 (ru) 2018-12-11
JP6278960B2 (ja) 2018-02-14
CA2879155C (en) 2024-04-30
KR20150036698A (ko) 2015-04-07
HUE036545T2 (hu) 2018-07-30
RU2015105738A (ru) 2016-09-10
BR112015001175B1 (pt) 2022-03-03
US20160361369A1 (en) 2016-12-15
US20180008651A1 (en) 2018-01-11
EP2875121A4 (en) 2016-01-13
DK2875121T3 (en) 2018-04-16
US9775867B2 (en) 2017-10-03
PL2875121T3 (pl) 2018-06-29
CN104736695B (zh) 2017-05-24
EP2875121B1 (en) 2018-01-03
EP2875121A1 (en) 2015-05-27
BR112015001175A2 (pt) 2017-06-27
PH12015500091B1 (en) 2015-03-02
PH12015500091A1 (en) 2015-03-02
WO2014012172A1 (en) 2014-01-23
RU2670882C2 (ru) 2018-10-25
US9453195B2 (en) 2016-09-27
KR102171028B1 (ko) 2020-10-28
PT2875121T (pt) 2018-03-14
MX2015000905A (es) 2015-09-28
CN104736695A (zh) 2015-06-24
MX363057B (es) 2019-03-06
HK1209780A1 (en) 2016-04-08

Similar Documents

Publication Publication Date Title
Kyriakis et al. The effect of probiotic LSP 122 on the control of post-weaning diarrhoea syndrome of piglets
Hayakawa et al. Dietary administration of probiotics to sows and/or their neonates improves the reproductive performance, incidence of post‐weaning diarrhea and histopathological parameters in the intestine of weaned piglets
RS57056B1 (sr) Nepatogeni soj f18 e.coli i njegova primena
Fairbrother et al. Escherichia coli in postweaning diarrhea in pigs: an update on bacterial types, pathogenesis, and prevention strategies
US20140219977A1 (en) Use of live bacteria for growth promotion in animals
Fairbrother et al. Escherichia coli infections
Diab et al. Diseases produced by Clostridium perfringens type C
Frederic et al. Application of high energy and protein diets in combination with a live avirulent Escherichia coli F4 vaccine against post-weaning diarrhea
Mathew et al. Effects of in-feed egg yolk antibodies on Salmonella shedding, bacterial antibiotic resistance, and health of pigs
Radulović et al. Neonatal diarrhea in pigs caused by Clostridium perfringens
Hodgson et al. Treatment and control of enterotoxigenic Escherichia coli infections in pigs.
Wu Studies on the impact of probiotic bacteria on enteric microbial diversity and immune response
HK1209780B (en) Non-pathogenic f18 e. coli strain and use thereof
Luppi et al. Escherichia
El Dimerdash et al. Studies on the effect of some probiotics in Rabbits
Eriksson The effect of probiotic administration on piglets perfor-mance and intestinal microbiota
Nhi et al. SWINE COLIBACILLOSIS IN PIG
Whitney Nutritional strategies to improve gastro-intestinal health in swine
Tchórzewska An in Vitro and in Vivo Assessment of Lactobacillus Plantarum and Lastulose as an Intervention Strategy Against S. Typhimurium in Pigs
Amezcua Post-weaning diarrhea and mortality caused by Escherichia coli: investigation of risk factors and control methods
Chernysheva Evaluation of egg yolk immunoglobulins in passive protection of post-weaned pigs against enterotoxigenic K88+ E. coli
Thornton Siderophore receptor and porin protein-based vaccine technology: an intervention strategy for pre-harvest control of Escherichia coli O157 in cattle
Yang Feed fermentation formulate gut microbiota of weanling pigs-Effects of exopolysaccharides and reutericyclin
Tissen et al. Shyhybayev. K. 2026. Enteral infectious diseases in calves: Etiology and management
Amezcua et al. Veterinary Therapeutics• Vol. 8, No. 3, Fall 2007